CHTR financial statements and SEC filings
CHTR annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $54.77B | $12.91B | $4.99B | 10-K |
| 2024-12-31 | $55.09B | $13.12B | $5.08B | 10-K |
| 2023-12-31 | $54.61B | $12.56B | $4.56B | 10-K |
| 2022-12-31 | $54.02B | $11.96B | $5.05B | 10-K |
| 2021-12-31 | $51.68B | $10.53B | $4.65B | 10-K |
| 2020-12-31 | $48.10B | $8.40B | $3.22B | 10-K |
CHTR annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $154.21B | $133.69B | $20.52B | 10-Q |
| 2024-12-31 | $150.02B | $130.31B | $19.71B | 10-K |
| 2023-12-31 | $147.19B | $132.47B | $14.72B | 10-K |
| 2022-12-31 | $144.52B | $131.97B | $12.55B | 10-K |
| 2021-12-31 | $142.49B | $124.33B | $18.16B | 10-K |
| 2020-12-31 | $144.21B | $113.92B | $30.28B | 10-K |
CHTR annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $16.08B | -$11.66B | -$4.37B | 10-K |
| 2024-12-31 | $14.43B | -$11.27B | -$3.98B | 10-K |
| 2023-12-31 | $14.43B | -$11.12B | -$3.24B | 10-K |
| 2022-12-31 | $14.93B | -$9.38B | -$5.77B | 10-K |
| 2021-12-31 | $16.24B | -$7.63B | -$8.88B | 10-K |
| 2020-12-31 | $14.56B | -$7.42B | -$8.95B | 10-K |